BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Heat shock transcription factor 1 (HSF1); MEK; proteasome

March 19, 2015 7:00 AM UTC

In vitro and mouse studies suggest promoting amyloidogenesis could help treat cancer. In multiple human cancer cell lines - but not normal cell lines - co-treatment with a MEK inhibitor and proteasome...